Sign in or 

The procedure, which is not approved in the United Kingdom, involves injecting umbilical cord blood stem cells into the patient's bloodstream and spinal canal, according to information from Beike Biotech, a biotechnology company based in Shenzhen, China. The company supplies stem cells at 11 hospitals in China and one in Thailand for cellular therapy for a variety of diseases. The new cells replace diseased or dysfunctional cells with functional ones, according to the company.
After patients receive stem-cell treatment and return home, it is suggested they receive oxygen treatment for 1 1/2 hours a day, five days a week, for one year to help the stem cells progress, Sallee says.
So far, the four children with optic-nerve diseases who have received stem-cell treatment have reported progress, says Kirshner Ross-Vaden, a registered nurse and Chicago-based vice president of foreign patient relations for Beike Biotech. The first treatment began in June.
"No one in the world has attempted to treat it," said Ross-Vaden, adding that 25 children are scheduled to go to China for treatment within the first six months of next year. "It's really amazing. The fact that no one had any hope for their child and literally almost overnight parents who were told their children would never see, have — for the first time in their lives — a realistic option."
Soon after receiving stem-cell treatments, Barlett, who was blind, was able to see light and recognize faces of her family up close, according to the family's online blog
|
holliemchugh |
Latest page update: made by holliemchugh
, Sep 8 2008, 9:53 AM EDT
(about this update
About This Update
75 words added view changes - complete history) |
|
Keyword tags:
None
More Info: links to this page
|